Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma

Plain-language summary

This study aimed to characterize patients with tuberous sclerosis complex, lymphangioleiomyomatosis and angiomyolipoma. Patients of all ages followed at a university hospital were assessed observationally. It was conducted as a non-phase observational study and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

InCor Heart Institute

Start date

4/1/2016

Estimated completion

8/1/2022

Countries

Brazil

Related genes

Locations

• São Paulo, Brazil
• São Paulo, Brazil
• São Paulo, Brazil

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* All patients with TSC, LAM (sporadic or associated with TSC) or AML (sporadic or associated with TSC or with LAM) followed at Hospital das Clínicas, University of São Paulo Medical School will be included in the proposed study. Patients of all ages will participate in the study.

Exclusion Criteria:

* There is no exclusion criteria.